Supplementation with chromium picolinate recovers renal Cr concentration and improves carbohydrate metabolism and renal function in type 2 diabetic mice

Biological Trace Element Research

Volumn 105, Issue 1-3, 2005, Pages 229-248

  Mita, Yukiko ^a   Ishihara, Kengo ^a   Fukuchi, Yoshiko ^a   Fukuya, Yoko ^a   Yasumoto, Kyoden ^a  

^a SUGIYAMA JOGAKUEN UNIVERSITY   (Japan)

Author keywords

Chromium picolinate; Diabetes; Hyperglycemia; ICP MS; KK Ay; Renal function

Indexed keywords

CHROMIUM PICOLINATE; CREATININE; GLUCOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DIABETIC OBESITY; DRUG EFFECT; DRUG EXCRETION; DRUG TISSUE LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; KIDNEY FUNCTION; MALE; MASS SPECTROMETRY; MICROALBUMINURIA; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; SUPPLEMENTATION; TREATMENT OUTCOME; URINARY EXCRETION; URINE LEVEL;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CARBOHYDRATE METABOLISM; CHROMIUM; CREATININE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DIETARY SUPPLEMENTS; GLUCOSE; GLUCOSE TOLERANCE TEST; INSULIN; IRON CHELATING AGENTS; KIDNEY; MALE; MICE; MICE, INBRED C57BL; PICOLINIC ACIDS; TIME FACTORS;

EID: 22444436664     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1385/BTER:105:1-3:229     Document Type: Article

References (36)

1. R. A. Anderson, Chromium as an essential nutrient for humans, Regul. Toxicol. Pharmacol. 26, S35-S41 (1997).
2. W. Mertz, Chromium in human nutrition: a review, J. Nutr. 123, 626-633 (1993).
3. R. A. Anderson, Chromium, glucose tolerance, and diabetes, Biol. Trace Element Res. 32, 19-24 (1992).
4. W. T. Cefalu, Z. Q. Wang, X. H. Zhang, L. C. Baldor, and J. C. Russell, Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats, J. Nutr. 132, 1107-1114 (2002).
5. R. A. Anderson, Chromium, glucose intolerance and diabetes, J. Am. Coll. Nutr. 17, 548-555 (1998).
6. A. R. Andersen, J. S. Christiansen, J. K. Andersen, S. Kreiner, and T. Deckert, Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study, Diabetologia 25, 496-501 (1983).
7. The Diabetes Control and Complication Trial Research Group, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N. Engl. J. Med. 329, 977-986 (1993).
8. W. Feng, W. Ding, Q. Qian, and Z. Chai, Comparison of the chromium distribution in organs and subcellular fractions of normal and diabetic rats by using enriched stable isotope Cr-50 tracer technique, Biol. Trace Element Res. 71-72, 121-129 (1999).
9. W. Ding, Z. Chai, P. Duan, W. Feng, and Q. Qian, Serum and urine chromium concentrations in elderly diabetics, Biol. Trace Element Res. 63, 231-237 (1998).
10. B. W. Morris, S. MacNeil, C. A. Hardisty, S. Heller, C. Burgin, and T. A. Gray, Chromium homeostasis in patients with type II (MDDM) diabetes, J. Trace Elements Med. Biol. 13, 57-61 (1999).
11. C. Ekmekcioglu, C. Prohaska, K. Pomazal, I. Steffan, G. Schernthanener, and W. Marktl, Concentrations of seven trace elements in different hematological matrices in patients with type 2 diabetes as compared to healthy controls, Biol. Trace Element Res. 79, 205-219 (2001).
12. R. A. Anderson, N. Cheng, N. A. Bryden, et al., Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes, Diabetes 46, 1786-1791 (1997).
13. T. Ghafghazi, A. Maghbareh, and R. Barnett, Chromium-induced hyperglycemia in the rat, Toxicology 12, 47-52 (1979).
14. W. Mertz, E. W. Toepfer, E. E. Roginski, and M. M. Polansky, Present knowledge of the role of chromium, Fed. Proc. 33, 2275-2280 (1974).
15. R. A. Anderson, M. M. Polansky, N. A. Bryden, S. J. Bhathena, and J. J. Canary, Effects of supplemental chromium on patients with symptoms of reactive hypoglycemia, Metabolism 36, 351-355 (1987).
16. J. F. Potter, P. Levin, R. A. Anderson, J. M. Freiberg, R. Andres, and D. Elahi, Glucose metabolism in glucose-intolerant older people during chromium supplementation, Metabolism 34, 199-204 (1985).
17. R. I. Press, J. Geller, and G. W. Evans, The effect of chromium picolinate on serum cholesterol and apolipoprotein fractions in human subjects, West. J. Med. 152, 41-45 (1990).
18. T. Aoyama, K. Fukui, K. Takamatsu, Y. Hashimoto, and T. Yamamoto, Soy protein isolate and its hydrolysate reduce body fat of dietary obese rats and genetically obese mice (yellow KK), Nutrition 16, 349-354 (2000).
19. N. Iritani, T. Sugimoto, H. Fukuda, M. Komiya, and H. Ikeda, Dietary soybean protein increases insulin receptor gene expression in Wistar fatty rats when dietary polyunsaturated fatty acid level is low, J. Nutr. 127, 1077-1083 (1997).
20. W. Feng, W. Ding, Q. Qian, and Z.Chai, Use of the enriched stable isotope Cr-50 as a tracer to study the metabolism of chromium(in) in normal and diabetic rats, Biol. Trace Element Res. 63, 129-138 (1998).
21. U. A. Shinde and R. K. Goyal, Effect of chromium picolinate on histopathological alterations in STZ and neonatal STZ diabetic rats, J. Cell. Mol. Med. 7, 322-329 (2003).
22. M. I. Uusitupa, L. Mykkanen, O. Siitonen, et al., Chromium supplementation in impaired glucose tolerance of elderly: effects on blood glucose, plasma insulin, C-peptide and lipid levels, Br. J. Nutr. 68, 209-216 (1992).
23. V. L. Thomas and S. S. Gropper, Effect of chromium nicotinic acid supplementation on selected cardiovascular disease risk factors, Biol. Trace Element Res. 55, 297-305 (1996).
24. C. M. Davis, K. H. Sumrall, and J. B. Vincent, A biologically active form of chromium may activate a membrane phosphotyrosine phosphatase (PTP), Biochemistry 35, 12,963-12,969 (1996).
25. C. M. Davis and J. B. Vincent, Chromium oligopeptide activates insulin receptor tyrosine kinase activity, Biochemistry 36, 4382-4385 (1997).
26. J. B. Vincent, The biochemistry of chromium, J. Nutr. 130, 715-718 (2000).
27. J. Cerulli, D. W. Grabe, I. Gauthier, M. Malone, and M. D. McGoldrick, Chromium picolinate toxicity Ann. Pharmacother. 32, 428-431 (1998).
28. W. G. Wasser, N. S. Feldman, and V. D. D'Agati, Chronic renal failure after ingestion of over-the-counter chromium picolinate, Ann. Intern. Med. 126, 410 (1997).
29. S. M. Bahijiri, S. A. Mira, A. M. Mufti, and M. A. Ajabnoor, The effects of inorganic chromium and brewer's yeast supplementation on glucose tolerance, serum lipids and drug dosage in individuals with type 2 diabetes, Saudi Med. J. 21, 831-837 (2000).
30. F. Uyanik, A. Atasever, S. Ozdamar, and F. Aydin, Effects of dietary chromium chloride supplementation on performance, some serum parameters, and immune response in broilers, Biol. Trace Element Res. 90, 99-115 (2002).
31. E. B. Kegley, J. W. Spears, and J. H. Eisemann, Performance and glucose metabolism in calves fed a chromium-nicotinic acid complex or chromium chloride, J. Dairy Sci. 80, 1744-1750 (1997).
32. Y. Kojima, Y. Yoshikawa, E. Ueda, et al., Blood glucose lowering and toxicological effects of zinc(II) complexes with maltol, threonine, and picolinic acid, Res. Commun. Mol. Pathol. Pharmacol. 112, 91-104 (2002).
33. M. Urberg and M. B. Zemel, Evidence for synergism between chromium and nicotinic acid in the control of glucose tolerance in elderly humans, Metabolism 36, 896-899 (1987).
34. A. H. Mehler, Formation of picolinic and quinolinic acids following enzymatic oxidation of 3-hydroxyanthranilic acid, J. Biol. Chem. 218, 241-254 (1956).
35. 2) coordination mode: structure characterization, in vitro, and in vivo studies, J. Biol. Inorg. Chem. 7, 68-73 (2002).
36. 2) coordination mode, and evaluation of its effect on uptake of D-glucose by Ehrlich ascites tumour cells, J. Pharm. Pharmacol. 51, 119-124 (1999).